Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Influenza: Page 3
Smartphone-based LAMP assay can detect COVID, flu
By
Leah Sherwood
Smart LAMP is portable and inexpensive to set up (less than $100, according to the authors) and consists of a hot plate, cardboard box, and LED lights. The researchers designed the diagnostic to meet five criteria for rapid and frequent testing at the point of care: speed, sensitivity, low cost, scalability, and accessibility. The assay simultaneously analyzes up to 96 saliva samples per phone at a cost of less than $7 per test, the researchers noted.
January 27, 2022
MilliporeSigma secures $137M contract from U.S. government
By
LabPulse.com staff writers
The award will cover a three-year period and is from the U.S. Department of Defense, on behalf of the U.S. Department of Health and Human Services; it is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness, the company said in a press release.
January 3, 2022
Applied BioCode receives EUA for SARS-CoV-2 combo assay
By
LabPulse.com staff writers
The assay can simultaneously detect and differentiate between SARS-CoV-2, influenza A with subtypes, and respiratory syncytial virus in nasopharyngeal swab specimens, the company said. The test is designed to assist physicians in evaluating patients with clinical signs and symptoms of respiratory infection.
December 16, 2021
Eurofins launches assay to detect omicron variant of COVID
By
LabPulse.com staff writers
Called GSD NovaType Detect + Select K417N SARS-CoV-2, the assay is designed for simultaneous qualitative detection of SARS-CoV-2 genomic RNA and identification of the spike mutation K417N in one reaction. The company said results can be obtained within one hour.
December 2, 2021
Eurofins debuts 2 combined tests for COVID/influenza, RSV
By
LabPulse.com staff writers
The new multiplex kits have been granted the CE Mark and are designed to detect and differentiate three viral infections in the same PCR run, Eurofins said.
November 30, 2021
Co-Diagnostics says its COVID tests effective vs. omicron variant
By
LabPulse.com staff writers
In a statement released by Co-Diagnostics, CEO Dwight Egan stated that the omicron variant, which has more than 50 mutations, does not interfere with the company's COVID-19 tests, including the following:
November 28, 2021
Scientists develop portable SARS-CoV-2 sensor on a chip
By
Leah Sherwood
"The sensor provided a rapid and sensitive detection platform with a detection limit of 57 pg/mL (3.7 copy/mL), 27-fold more sensitive than RT-PCR," wrote the authors, led by Heba Hussein, PhD, of the Animal Health Research Institute at the Agricultural Research Center in Giza, Egypt.
November 16, 2021
BD secures BARDA funds for development of COVID-19 test
By
LabPulse.com staff writers
Under terms of the deal, BARDA will extend its support to BD by up to $40.3Â million for the development and U.S. Food and Drug Administration (FDA) clearance of five new tests:
November 1, 2021
PerkinElmer receives EUA for respiratory SARS-CoV-2 panel
By
LabPulse.com staff writers
Qualified laboratories can immediately begin using the RT-PCR test for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) isolated from nasopharyngeal swabs, anterior nasal swabs, and midturbinate swabs, the company said.
October 6, 2021
Longhorn to partner with SiO2
By
LabPulse.com staff writers
The tubes will help large clinical labs with high sample volumes to pool more samples with less required material, according to Longhorn. They are available for COVID-19, influenza, and other virus testing.
October 3, 2021
Flu shots may protect against severe COVID-19
By
LabPulse.com staff writers
The annual flu shot may reduce the risks of stroke, sepsis, and deep vein thrombosis (DVT) in patients with COVID-19. Also, those who received influenza vaccines were significantly less likely to visit emergency departments and be admitted to intensive care units, according to the findings.
August 3, 2021
Quidel secures CE Mark for Savanna molecular analyzer, assay
By
LabPulse.com staff writers
Savanna allows users to analyze 12 pathogens in a single test that lasts less than 30 minutes, according to Quidel. Its Savanna RVP4 Assay is a nucleic acid test to detect influenza, respiratory syncytial virus, and SARS-CoV-2, the company said.
July 11, 2021
Previous Page
Page 3 of 7
Next Page